Simplified kinetic analysis of tumor 18F-FDG uptake: A dynamic approach

Journal of Nuclear Medicine

Volumn 45, Issue 8, 2004, Pages 1328-1333

  Sundaram, Senthil K ^a   Freedman, Nanette M T ^b   Carrasquillo, Jorge A ^a   Carson, Joann M ^a   Whatley, Millie ^a   Libutti, Steven K ^a   Sellers, David ^a   Bacharach, Stephen L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

18F FDG; Patlak; Standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; KIDNEY CANCER; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; BLOOD; BREAST TUMOR; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED CLINICAL TRIAL; ISOTOPE DILUTION ASSAY; KIDNEY SCINTISCANNING; KIDNEY TUMOR; KINETICS; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STANDARD; VALIDATION STUDY;

BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KIDNEY NEOPLASMS; KINETICS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RADIOISOTOPE DILUTION TECHNIQUE; RADIOISOTOPE RENOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 4544381250     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med. 1995;36:1836-1839.
2. Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med. 1994;35:1308-1312.
3. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Cereb Blood Flow Metab. 1983;3:1-7.
4. Graham MM, Peterson LM, Hayward RM. Comparison of simplified quantitative analyses of FDG uptake. Nucl Med Biol. 2000;27:647-655.
5. Hunter GJ, Hamberg LM, Alpert NM, Choi NC, Fischman AJ. Simplified measurement of deoxyglucose utilization rate. J Nucl Med. 1996;37:950-955.
6. Wong WH, Hicks K. A clinically practical method to acquire parametric images of unidirectional metabolic rates and blood spaces. J Nucl Med. 1994;35:1206-1212.
7. Tsuchida T, Sadato N, Yonekura Y, et al. Noninvasive measurement of cerebral metabolic rate of glucose using standardized input function. J Nucl Med. 1999;40:1441-1445.
8. 18F]fluoro-2-deoxy-d-glucose studies. J Nucl Med. 1991;32:733-738.
9. Gambhir SS, Schwaiger M, Huang SC, et al. Simple noninvasive quantification method for measuring myocardial glucose-utilization in humans employing positron emission tomography and F-18 deoxyglucose. J Nucl Med. 1989;30:359-366.
10. Hoh CK, Levin CS, Vera DR. Whole body Patlak imaging. J Nucl Med. 2003;44(suppl):61P.
11. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med. 1994;35:1398-1406.
12. Weber W, Ziegler SI, Thodtmann R, Hanauske AR, Schwaiger M. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med. 1999;40:1771-1777.
13. 18F)-2-fluoro-2-deoxy-D- glucose and positron emission tomography: an overview of different analytical methods. Eur J Nucl Med. 2000;27:731-743.
14. Freedman NM, Sundaram SK, Kurdziel K, et al. Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans. Eur J Nucl Med Mol Imaging. 2003;30:46-53.